Quarterly report · Q3
2533.TEDINET S100PEZ2
Period2022-01-01 → 2022-09-30
Filed2022-11-04
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥58.0bn | 2022-01-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥78.6bn | 2021-01-01 → 2021-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥56.8bn | 2021-01-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | −¥869m | 2022-01-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥952m | 2021-01-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | −¥799m | 2022-01-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.3bn | 2021-01-01 → 2021-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥993m | 2021-01-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | −¥909m | 2022-01-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥278m | 2021-01-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥1.4bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥299m | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥206m | 2021-01-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥1.5bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥188m | 2021-01-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥52.5bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥52.3bn | at 2021-12-31 | Cons. | Assets |
| Total assets | ¥49.5bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥32.2bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥30.2bn | at 2021-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥20.3bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥22.0bn | at 2021-12-31 | Cons. | Net assets |
| Net assets / equity | ¥22.1bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥631m | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥990m | at 2021-12-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥-22.73 | 2022-01-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-10.21 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥5.03 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥3.48 | 2021-01-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.91 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 35.1% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.3% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.5% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-01-01 → 2022-09-30 | ¥57m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-01-01 → 2022-09-30 | ¥57m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-09-30 | ¥11m |
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-09-30 | −¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-01 → 2022-09-30 | −¥2m |
| jpcrp040300-q3r_E00397-000Enzymatic Medicinereportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥2.7bn |
| jpcrp040300-q3r_E00397-000Enzymatic Medicinereportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥2.7bn |
| jpcrp040300-q3r_E00397-000Enzymatic Medicinereportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥381m |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥51.9bn |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥51.9bn |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | revenue intersegment | 2022-01-01 → 2022-09-30 | ¥2m |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | segment profit | 2022-01-01 → 2022-09-30 | −¥1.1bn |
| jpcrp040300-q3r_E00397-000Real Estatereportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥286m |
| jpcrp040300-q3r_E00397-000Real Estatereportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥286m |
| jpcrp040300-q3r_E00397-000Real Estatereportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥151m |
| jpcrp040300-q3r_E00397-000Starch For Processingreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥3.1bn |
| jpcrp040300-q3r_E00397-000Starch For Processingreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥3.1bn |
| jpcrp040300-q3r_E00397-000Starch For Processingreportable segment | segment profit | 2022-01-01 → 2022-09-30 | −¥273m |
| —segment total | revenue | 2022-01-01 → 2022-09-30 | ¥57.9bn |
| —segment total | revenue external | 2022-01-01 → 2022-09-30 | ¥57.9bn |
| —segment total | revenue intersegment | 2022-01-01 → 2022-09-30 | ¥2m |
| —segment total | segment profit | 2022-01-01 → 2022-09-30 | −¥880m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-01-01 → 2021-09-30 | ¥50m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-01-01 → 2021-09-30 | ¥50m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-01-01 → 2021-09-30 | ¥9m |
| Reconciling Itemsreconciling | revenue | 2021-01-01 → 2021-09-30 | −¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-01-01 → 2021-09-30 | −¥1m |
| jpcrp040300-q3r_E00397-000Enzymatic Medicinereportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥2.7bn |
| jpcrp040300-q3r_E00397-000Enzymatic Medicinereportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥2.7bn |
| jpcrp040300-q3r_E00397-000Enzymatic Medicinereportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥505m |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥51.0bn |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥51.0bn |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | revenue intersegment | 2021-01-01 → 2021-09-30 | ¥1m |
| jpcrp040300-q3r_E00397-000Liquorreportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥318m |
| jpcrp040300-q3r_E00397-000Real Estatereportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥265m |
| jpcrp040300-q3r_E00397-000Real Estatereportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥265m |
| jpcrp040300-q3r_E00397-000Real Estatereportable segment | segment profit | 2021-01-01 → 2021-09-30 | ¥139m |
| jpcrp040300-q3r_E00397-000Starch For Processingreportable segment | revenue | 2021-01-01 → 2021-09-30 | ¥2.8bn |
| jpcrp040300-q3r_E00397-000Starch For Processingreportable segment | revenue external | 2021-01-01 → 2021-09-30 | ¥2.8bn |
| jpcrp040300-q3r_E00397-000Starch For Processingreportable segment | segment profit | 2021-01-01 → 2021-09-30 | −¥20m |
| —segment total | revenue | 2021-01-01 → 2021-09-30 | ¥56.7bn |
| —segment total | revenue external | 2021-01-01 → 2021-09-30 | ¥56.7bn |
| —segment total | revenue intersegment | 2021-01-01 → 2021-09-30 | ¥1m |
| —segment total | segment profit | 2021-01-01 → 2021-09-30 | ¥943m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 421
| Item | Context | Value | Unit |
|---|---|---|---|
| Deferred gains or losses on hedges net of tax oci | Prior1YTDDuration | 72000000 | JPY |
| Deferred gains or losses on hedges net of tax oci | CurrentYTDDuration | 164000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | Prior1YTDDuration | -6000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | CurrentYTDDuration | -5000000 | JPY |
| Other comprehensive income | Prior1YTDDuration | 260000000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 201000000 | JPY |
| Comprehensive income | Prior1YTDDuration | 449000000 | JPY |
| Comprehensive income | CurrentYTDDuration | -1298000000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 465000000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | -1151000000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | -16000000 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | -147000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E00397-000LiquorReportableSegmentsMember | 50963000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E00397-000StarchForProcessingReportableSegmentsMember | 2794000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E00397-000EnzymaticMedicineReportableSegmentsMember | 2690000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E00397-000RealEstateReportableSegmentsMember | 265000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 56714000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 50000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 56765000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E00397-000LiquorReportableSegmentsMember | 1000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E00397-000StarchForProcessingReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E00397-000EnzymaticMedicineReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E00397-000RealEstateReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | 1000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -1000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E00397-000LiquorReportableSegmentsMember | 50965000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E00397-000StarchForProcessingReportableSegmentsMember | 2794000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E00397-000EnzymaticMedicineReportableSegmentsMember | 2690000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E00397-000RealEstateReportableSegmentsMember | 265000000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 56716000000 | JPY |
| Net sales | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 50000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -1000000 | JPY |
| Net sales | Prior1YTDDuration | 56765000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E00397-000LiquorReportableSegmentsMember | 318000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E00397-000StarchForProcessingReportableSegmentsMember | -20000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E00397-000EnzymaticMedicineReportableSegmentsMember | 505000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E00397-000RealEstateReportableSegmentsMember | 139000000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 943000000 | JPY |
| Operating income | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 9000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Operating income | Prior1YTDDuration | 952000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E00397-000LiquorReportableSegmentsMember | 51890000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E00397-000StarchForProcessingReportableSegmentsMember | 3070000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E00397-000EnzymaticMedicineReportableSegmentsMember | 2688000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E00397-000RealEstateReportableSegmentsMember | 286000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 57934000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 57000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |